Effects of Mycobacterium avium complex-infection treatment on cytokine expression in human immunodeficiency virus-infected persons: results of AIDS clinical trials group protocol 853

J Infect Dis. 2000 Apr;181(4):1486-90. doi: 10.1086/315370. Epub 2000 Apr 13.

Abstract

Human immunodeficiency virus (HIV) type 1-infected persons with newly diagnosed Mycobacterium avium complex (MAC) bacteremia were enrolled in an 8-week study to determine whether treatment of MAC infection is associated with decreases in plasma tumor necrosis factor (TNF)-alpha levels. Blood specimens were obtained for quantitative MAC cultures and to determine plasma levels of HIV RNA, TNF-alpha, and other proinflammatory cytokines. MAC levels decreased by 1.75 log at week 4 (P=.008) and by 2.48 log at week 8 (P=.001). Plasma TNF-alpha decreased by 0.15 log at week 4 (P=.042) and by 0. 40 log at week 8 (P=.027). Plasma interleukin (IL)-6 decreased by 0. 56 log at week 8 (P=.039). There were nonsignificant trends (P<.10) for plasma levels of IL-1beta and HIV RNA to decrease at week 8. Nonsignificant decreases in plasma levels of TNF-alpha, IL-1beta, IL-6, and HIV RNA were also seen in those individuals who remained on stable antiretroviral therapy throughout the 8 weeks of the study.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • AIDS-Related Opportunistic Infections / blood*
  • AIDS-Related Opportunistic Infections / drug therapy*
  • Adult
  • Anti-Bacterial Agents / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Clarithromycin / therapeutic use
  • Cytokines / blood*
  • Ethambutol / therapeutic use
  • Humans
  • Interleukin-1 / blood
  • Interleukin-6 / blood
  • Mycobacterium avium-intracellulare Infection / blood*
  • Mycobacterium avium-intracellulare Infection / drug therapy*
  • Pilot Projects
  • RNA, Viral / analysis
  • Rifabutin / therapeutic use
  • Tumor Necrosis Factor-alpha / metabolism
  • Viral Load

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents
  • Cytokines
  • Interleukin-1
  • Interleukin-6
  • RNA, Viral
  • Tumor Necrosis Factor-alpha
  • Rifabutin
  • Ethambutol
  • Clarithromycin